There’s been a flurry of activity on the Chinese vaccine distribution front. Over the weekend, a growing number of countries across the Global South are taking delivery of Chinese-made COVID-19 vaccines even before they completed clinical trials or received WHO pre-qualification.
These countries, many in the Middle East, South America, and Asia, are all becoming increasingly concerned that they’re going to be left behind in gaining access to vaccines due to widespread vaccine hoarding by wealthier countries.
